Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer
暂无分享，去创建一个
J. Flanagan | C. Crews | Y. Qian | J. Bradley | I. Taylor | G. Cadelina | Ryan R. Willard | A. Crew | J. Houston | E. Rousseau | R. Peck | S. Gough | M. Andreoli | J. Chandler | Lawrence Snyder | J. Pizzano | M. Bookbinder | Marcia Dougan Moore | Jennifer Pizzano